| Sign In to gain access to subscriptions and/or personal tools. |
Post-translational Regulation of Runx2 in Bone and Cartilage
1 Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, 601 Elmwood Avenue, Box 665, Rochester, NY 14642, USA; Correspondence: * di_chen{at}urmc.rochester.edu The Runx2 gene product is essential for mammalian bone development. In humans, Runx2 haploinsufficiency results in cleidocranial dysplasia, a skeletal disorder characterized by bone and dental abnormalities. At the molecular level, Runx2 acts as a transcription factor for genes expressed in hypertrophic chondrocytes and osteoblasts. Runx2 gene expression and protein function are regulated on multiple levels, including transcription, translation, and post-translational modification. Furthermore, Runx2 is involved in numerous protein-protein interactions, most of which either activate or repress transcription of target genes. In this review, we discuss expression of Runx2 during development as well as the post-translational regulation of Runx2 through modification by phosphorylation, ubiquitination, and acetylation.
Key Words: Runx2 phosphorylation ubiquitination degradation PTHrP
Journal of Dental Research, Vol. 88, No. 8,
693-703 (2009) |
|
|||
